- Home
- YCBD vs VTAK Comparison
YCBD vs VTAK Comparison
Compare YCBD & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YCBD
- VTAK
- Stock Information
- Founded
- YCBD 2015
- VTAK 2002
- Country
- YCBD United States
- VTAK United States
- Employees
- YCBD N/A
- VTAK N/A
- Industry
- YCBD Biotechnology: Pharmaceutical Preparations
- VTAK Medical/Dental Instruments
- Sector
- YCBD Health Care
- VTAK Health Care
- Exchange
- YCBD Nasdaq
- VTAK Nasdaq
- Market Cap
- YCBD 1.6M
- VTAK 1.4M
- IPO Year
- YCBD N/A
- VTAK 2018
- Fundamental
- Price
- YCBD $0.50
- VTAK $0.46
- Analyst Decision
- YCBD
- VTAK
- Analyst Count
- YCBD 0
- VTAK 0
- Target Price
- YCBD N/A
- VTAK N/A
- AVG Volume (30 Days)
- YCBD 3.2M
- VTAK 734.4K
- Earning Date
- YCBD 02-11-2025
- VTAK 11-13-2024
- Dividend Yield
- YCBD N/A
- VTAK N/A
- EPS Growth
- YCBD N/A
- VTAK N/A
- EPS
- YCBD N/A
- VTAK N/A
- Revenue
- YCBD $19,482,167.00
- VTAK $399,000.00
- Revenue This Year
- YCBD $13.00
- VTAK $38.46
- Revenue Next Year
- YCBD N/A
- VTAK $533.33
- P/E Ratio
- YCBD N/A
- VTAK N/A
- Revenue Growth
- YCBD N/A
- VTAK 27.07
- 52 Week Low
- YCBD $0.31
- VTAK $0.31
- 52 Week High
- YCBD $1.34
- VTAK $4.10
- Technical
- Relative Strength Index (RSI)
- YCBD 53.41
- VTAK 51.41
- Support Level
- YCBD $0.42
- VTAK $0.40
- Resistance Level
- YCBD $0.82
- VTAK $0.51
- Average True Range (ATR)
- YCBD 0.12
- VTAK 0.07
- MACD
- YCBD 0.01
- VTAK -0.00
- Stochastic Oscillator
- YCBD 34.18
- VTAK 34.35
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD and hempMD. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.